McKinsey No Longer Consulting for Purdue, Ends Opioid Work
- Consulting firm worked with pain giant for at least a decade
- Purdue had already halted promotion of drugs to doctors
This article is for subscribers only.
McKinsey & Co. said it is no longer working with drugmaker Purdue Pharma LP and will stop all other work related to the sale of the pain pills that have been blamed for an epidemic of U.S. abuse and death.
“We are no longer advising clients on any opioid-specific business and are continuing to support key stakeholders working to combat the crisis,” the storied consulting firm said in a statement.